Our platform is a way to study fat cells outside a human or animal body, or in vitro. Our stem-cell platform, M3, is unique in its accuracy in replicating human fat cells.
Dr. Aaron Glieberman is Senior Engineer of Platform Development at MelliCell.
He is a biomedical engineer with wide-ranging experience in device development, tissue engineering, and synthetic biology, with a recent focus on design and fabrication of organ-on-a-chip microfluidics with integrated sensing capabilities.
Aaron is committed to tackling intractable problems in healthcare, working to identify quantifiable metrics to map the spectrum between health and disease.
Copyright © 2024 MelliCell. All Rights Reserved.